Key points are not available for this paper at this time.
An accurate prognostic model for acute myeloid leukemia (AML) can guide personalized treatment. In our prospective cohort of 591 patients newly diagnosed with AML, we evaluated the prognostic significance of serum albumin levels. We recognized baseline serum albumin as a prognostic factor by univariate Cox regression analysis (albumin-high vs albumin-low: overall survival OS: hazard ratio HR: 0.679, 95% confidence interval CI: 0.529-0.870,
Chen et al. (Mon,) studied this question.